Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-09-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
独立董事关于公司第三届董事会第二十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding matters discussed at the company's third board of directors' 24th meeting. It includes opinions on board re-election, adjustments to investment structures of fundraising projects, and the use of temporarily idle raised funds for cash management. The document references compliance with securities laws, stock exchange listing rules, and company articles of association. It is a formal statement related to board and management decisions rather than a full financial report, earnings release, or regulatory filing. The content focuses on board-related matters and independent directors' opinions on governance and fundraising project management. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a report publication announcement or regulatory filing as it contains substantive independent opinions on board matters.
2019-09-24 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There is no financial data, no mention of financial results, no report or presentation format, and no voting results. The content is focused on board/management information, specifically about a board member nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 3449 characters, which is consistent with a detailed announcement rather than a full report.
2019-09-24 Chinese
关于调整部分募投项目投资结构等相关事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding adjustments to the investment structure of certain projects funded by proceeds from a convertible bond issuance. It details the original and adjusted investment amounts, reasons for adjustments, and approvals from the board, independent directors, supervisors, and the sponsoring institution. The document references regulatory approvals and compliance with securities regulations. It does not contain full financial statements or comprehensive financial performance data, nor is it a transcript, audit report, or earnings release. It is a detailed update on capital use and project investment structure changes related to fundraising proceeds. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2019-09-24 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the board and supervisory committee meetings approving the use of up to 180 million RMB of idle raised funds to purchase low-risk financial products. The document includes information about the raised funds, investment projects, risk analysis, approvals, and opinions from independent directors and the sponsor institution. It is a regulatory announcement about the company's financing fund usage and cash management strategy, not a full financial report, earnings release, or audit report. The document length is 3940 characters, which is relatively short and consistent with an announcement rather than a full report. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-09-24 Chinese
关于控股股东部分股份解除质押的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the partial release of pledged shares by its controlling shareholder. It details the number of shares released from pledge, dates, and the proportion of shares pledged and released. The content focuses on share pledge status and changes, which is related to shareholding and capital structure changes. The document length is short (1052 characters) and it is an announcement of a specific event concerning shares, not a full financial report or audit. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2019-09-23 Chinese
关于公司控股股东股权部分转让过户完成暨实际控制人变更完成的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the completion of a partial transfer of equity of the company's controlling shareholder and the resulting change in actual control of the company. It details the share transfer agreement, payment milestones, registration of the transfer, and the new controlling party. There is no financial data, no report attached or referenced as being published, and no mention of an annual or interim report. The document is a formal disclosure of a change in control and shareholder structure, which fits the category of Major Shareholding Notification (MRQ).
2019-09-19 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.